Showing results (1211-1220 of 1,243) with videos related to

Sort By:
Pageof 125
The Lancet Regional Health. Europe|October 24, 2024
Immunogenicity of concomitant SARS-CoV-2 and influenza vaccination in UK healthcare workers: a prospective longitudinal observational studyJoshua Nazareth, Christopher A Martin, Daniel Pan, et al.
Journal of General Internal Medicine|June 28, 2024
Comparative Effectiveness of Patient-Driven versus Standardized Diabetes Shared Medical Appointments: A Pragmatic Cluster Randomized TrialBethany M Kwan, L Miriam Dickinson, Jennifer Dailey-Vail, et al.
Biological Reviews of the Cambridge Philosophical Society|August 3, 2016
Exorcising Grice's ghost: an empirical approach to studying intentional communication in animalsSimon W Townsend, Sonja E Koski, Richard W Byrne, et al.
Human Reproduction Open|March 22, 2019
A protocol developing, disseminating and implementing a core outcome set for infertilityJ M N Duffy, S Bhattacharya, C Curtis, et al.
Nature Communications|June 3, 2023
Strain-tunable Berry curvature in quasi-two-dimensional chromium tellurideHang Chi, Yunbo Ou, Tim B Eldred, et al.
Veterinary and Comparative Oncology|January 13, 2012
Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumoursC London, T Mathie, N Stingle, et al.
Brain, Behavior, and Immunity|March 2, 2011
Brain inflammation is induced by co-morbidities and risk factors for strokeCaroline Drake, Hervé Boutin, Matthew S Jones, et al.
Plos One|April 30, 2015
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional StudyCheryl A London, Heather L Gardner, Tamra Mathie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2026
A Phase 1 and Biodistribution study of Ifabotuzumab, a humanized agonistic EphA3-targeted antibody, in patients with recurrent glioblastomaHui K Gan, Lawrence Cher, Po-Ling Inglis, et al.
Nature Medicine|February 9, 2026
Extracorporeal liver cross-circulation using transgenic xenogeneic pig livers with brain-dead human decedentsAbraham Shaked, Alex Sagar, Kim M Olthoff, et al.
Pageof 125